Category Archives: Treatment as Prevention

  1. Concerns about Gilead’s Truvada used as HIV Prevention

    via Financial Times, by Christine Livoti Gilead Sciences’ (NASDAQ: GILD) once-daily Truvada pill has seen only tepid interest for adoption in the HIV prevention setting, despite treatment guidelines by the Centers for Disease Control (CDC), experts told Biopharm Insight. This is largely related to issues around feasibility, cost and historical evidence for other prevention strategies, which may Read More >>

    FDA, Gilead, HPTN052, new prevention technologies, Treatment as Prevention, Truvada, United States
  2. PrEP: Attitudes and Acceptance Among Potential User Groups

    via PLoS One, by Andreas B. Eisingerich, Ana Wheelock, Gabriela B. Gomez, Geoffrey P. Garnett, Mark R. Dybul, Peter K. Piot Background The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposure prophylaxis (PrEP) has shown promising results in recent trials. To understand the potential impact of PrEP for HIV prevention, Read More >>

    acceptability, MSM, PrEP, prevention, risk, Treatment, Treatment as Prevention
  3. Pros and Cons of Treatment as Prevention

    via a&u, by Jeannie Gibbs Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative people in order to prevent HIV infection. In light of recently released data, a heated debate is raging in the HIV community on how and if PrEP should be implemented. A vast array of ethical, financial, and medical concerns have been Read More >>

    ARVs, HIV transmission, pre-exposure prophylaxis, PrEP, Treatment as Prevention
  4. Behavioral or Biomedical… Or both?!

    via gaycitynews.com, by Perry N. Halkitis, Ph.D., M.S “But is this radical shift from the behavioral to the biomedical the right course of action for all of us?   For me there are two bigger issues — one which I will fully address here, and the other to which I will allude.” Despite our best attempts over Read More >>

    ARV, biomedical, PrEP, sexual behavior, Treatment as Prevention
  5. Don’t Delay HIV Prevention for Gay and Bi Men

    via The Huffington Post, by David Ernesto Munar Lives will be saved when the Food and Drug Administration puts its stamp of approval on a groundbreaking preventative approach called pre-exposure prophylaxis, or PrEP, recently found to reduce HIV infections. With PrEP, people who are not infected with HIV take a daily pill, usually used to treat the Read More >>

    AIDS Foundation of Chicago, Bisexual, FDA, gay men, lgbt community, PrEP, transgendered, Treatment as Prevention, Truvada, United States
  6. Treatment alone will not win war against HIV

    via Cape Argus, by Sipokazi Fokazi If South Africa is to win the battle against HIV/Aids it cannot rely solely on treatment, and must explore prevention strategies that would target those most at risk, including women and children, a Cape Town scientist and HIV researcher has cautioned. Professor Linda-Gail Bekker, head of the Desmond Tutu HIV Centre, at Read More >>

    drugs, Microbicides, South Africa, Treatment as Prevention
  7. Questions Surround PrEP Trials

    via The New York Times, by David Tuller In the past year, three landmark clinical trials have shown that a daily dose of the antiretroviral medication Truvada can protect individuals from infection with H.I.V. — a significant discovery, given the failure so far of all efforts to develop a vaccine against the virus. Now researchers in San Read More >>

    gay men, MSM, PrEP, Treatment as Prevention, United States
  8. The Latest Treatment Action Campaign (TAC) Briefing – Antiretrovirals and Prevention

    via the Treatment Action Campaign (TAC), by Catherine Tomlinson and Nathan Geffen Exciting new evidence has demonstrated the potential of antiretroviral medicines (ARVs) to prevent HIV from being sexually transmitted. This TAC briefing explains the evidence and then discusses policy implications. Our recommendations 1.The WHO must release its guidelines on serodiscordant couples.2.People living with HIV should be Read More >>

    ART, FEM-PrEP, HIV/AIDS policy, HPTN052, Microbicides, PrEP, Treatment Action Campaign, Treatment as Prevention, WHO
  9. Plasma and rectal viral load correlated in HIV-positive gay men: supports use of treatment as prevention

    via European AIDS Treatment Group, by Michael Carter Viral load in the blood and rectal secretions of HIV-positive gay men are highly correlated, according to US research published in the September 1st edition of the Journal of Infectious Diseases. The study also showed that the presence of sexually transmitted infections did not increase rectal viral load. Individuals Read More >>

    antiretroviral therapy, HIV, MSM, rectal transmission, Treatment, Treatment as Prevention, viral load
  10. Early ARV Treatment Will Save Lives in South Africa

    Via All Africa. Government’s decision to offer free ARV treatment to people with CD4 counts of 350 or less has been welcomed as a life-saver. The South African government’s announcement that it will give antiretroviral medication to people with HIV who have CD4 counts of below 350 will save lives and prevent infection. This is according to Read More >>

    Africa, antiretroviral therapy, ARVs, HIV/AIDS policy, South Africa, Treatment, Treatment as Prevention